0HNC Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - BioMarin Pharmaceutical Inc

Watchlist Manager

Watchlist

Price: 59.3587 USD -2.06% Market Closed

Market Cap: $11.4B

	BioMarin Pharmaceutical Inc LSE:0HNC	US
S	Sasol Ltd XMUN:SAOA	ZA

Profitability Summary

BioMarin Pharmaceutical Inc's profitability score is 56/100. We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

80%

Strong 3Y Average Gross Margin

80%

Gross Margin is Increasing

78% > 80%

Healthy Operating Margin

20%

Sustainable 3Y Average Operating Margin

18%

Operating Margin is Increasing

5% > 20%

Low Net Margin

Sustainable 3Y Average Net Margin

11%

Declining Net Margin

6% > 2%

Exceptional Free Cash Flow Margin

21%

Strong 3Y Average Free Cash Flow Margin

15%

Free Cash Flow Margin is Increasing

View All

Hide

Collapse

56 / 100

Profitability
Score

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.